VIENNA--(BUSINESS WIRE)--Sep 15, 2025--
DexCom, Inc. (Nasdaq: DXCM), a global leader in glucose biosensing, will present new product features and a compilation of new evidence that shows the benefits of its glucose biosensing technology for people with all types of diabetes at the upcoming 61 st annual European Association for the Study of Diabetes (EASD) Conference.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250915690916/en/
“Each year, EASD provides a high-profile opportunity to highlight our latest product innovations and new clinical data that demonstrates how Dexcom glucose biosensing technology can empower people with all types of diabetes across the globe to take control of their health, while reinforcing Dexcom CGM as a cost-effective solution for diabetes management,” said Jake Leach, president and chief operating officer of Dexcom. “With one of our most exciting new features, Dexcom Smart Basal, now under FDA and CE mark review, we are aiming to deliver a simpler and easier basal titration process that helps patients and providers alike.”
Dexcom’s symposium presentation will showcase how Dexcom CGM improves health outcomes and can help mitigate complications, such as diabetic ketoacidosis, eye diseases, heart disease, and severe hypoglycemia. 4,5-6 The symposium is chaired by diabetes physician Dr. Sufyan Hussain, MD, PhD, UK, and will feature endocrinology experts Prof. Anne Peters, MD, United States, and Assoc. Prof. Halis Akturk, MD, United States. The symposium will close with a product update from Leach, including the announcement of the upcoming Dexcom Smart Basal feature.
Dexcom CGM: The choice for improving health outcomes and cost-effectiveness across diabetes types
Dexcom is presenting several abstracts during the five-day conference showcasing clinical and real-world evidence that support the benefits of Dexcom glucose biosensing. Key abstract highlights include:
Dexcom’s symposium ‘Dexcom CGM Improves Health Outcomes’ will take place on Monday, Sept. 15 at 15:30-16:30 CEST, in Warsaw Hall at the EASD 2025 Conference in Vienna, Austria. For more information about the symposium and other clinical data being presented by Dexcom during the conference, visit theDexcom EASD microsite.
About DexCom, Inc.
Dexcom empowers people to take control of health through innovative biosensing technology. Founded in 1999, Dexcom has pioneered and set the standard in glucose biosensing for more than 25 years. Its technology has transformed how people manage diabetes and track their glucose, helping them feel more in control and live more confidently.
Dexcom. Discover what you’re made of. For more information, visit www.dexcom.com.
Category: IR
*Dexcom Smart Basal is 510(k) and CE Mark pending. Not available for sale or distribution in the United States. †Dexcom data on file. 1 Acosta-Manzano P, et al. The effects of pre-meal and post-meal exercise on postprandial glucose excursions in pregnant women with type 1 diabetes. Presented at EASD 2025. 2 Linder T, et al. Glycaemic control and pregnancy outcomes with real-time continuous glucose monitoring in gestational diabetes (GRACE): an open-label, international, randomised controlled trial. Presented at EASD 2025. 3 van Genugten M, et al. Impact of real-time continuous glucose monitoring (rt-CGM) devices among insulin-treated type 2 diabetes patients in France. Presented at EASD 2025. 4 Bogun MM, et al. Real-time continuous glucose monitoring vs hourly point-of-care testing in diabetic ketoacidosis: impact on clinical outcomes. Presented at EASD 2025. 5 Reed J, et al. Continuous glucose monitoring for glycaemic control and cardiovascular risk reduction in patients with type 2 diabetes not on insulin therapy: A clinical trial. 2024. 6 Alshannaq H, et al. Cost-effectiveness of real-time continuous glucose monitoring people with type 2 diabetes on insulin therapy in Japan. Presented at EASD 2025. 7 Beck E, et al. Non-adjunctive continuous glucose monitoring for control of hypoglycemia (COACH): Results of a post-approval observational study showed the mean (SE) per-patient frequency of hypoglycemic events decreased by 63% from 0.08 (0.016) during the SMBG phase to 0.03 (0.010) during the RT-CGM phase (p = 0.005).
The company will unveil Dexcom Smart Basal, a new integrated titration module designed to make basal insulin initiation and management easier† for users, which is currently under FDA and CE mark review.
Findings will demonstrate how CGM can reduce neonatal complications linked to gestational diabetes more effectively than fingersticks.
BOSTON (AP) — Jurors began deliberating Friday in the murder trial of Brian Walshe, the Massachusetts man accused of killing and dismembering his wife more than two years ago.
Ana Walshe’s body has never been found since she disappeared on New Year’s Day 2023. The same day his wife was last seen alive, Walshe went to multiple pharmacies and hardware stores to buy heavy-duty cleaning supplies, a Tyvek protective suit and a utility knife, according to prosecutors.
He made the trips after early morning internet searches including, “How long before a body starts to smell?” and “Dismemberment and best ways to dispose of a body.” Over the next several days, prosecutors said, he looked for information online about how to cut apart a body into pieces with a hacksaw, not reporting his wife missing until one of her colleagues noticed her absence from work and contacted police.
On the day jury selection had been set to begin last month, Walshe pleaded guilty to misleading police and dismembering his wife's body, but hopes to convince jurors that he didn’t kill her. His attorneys have tried to put reasonable doubt in jurors' minds, acknowledging that Walshe lied to investigators while arguing he panicked after discovering Ana dead at their home following a New Year’s Eve gathering.
His attorneys rested Thursday without calling any witnesses, despite speculation that Walshe might testify.
When questioned by authorities after Ana was reported missing, Walshe told police his wife had left Massachusetts on New Year’s Day for a work emergency in Washington, D.C., though witnesses testified there was no record of her booking a ride or boarding a flight. He did not contact her employer until Jan. 4.
He later admitted that he dismembered her body and disposed of it in dumpster, saying that he did so only after panicking when he found his wife had died in bed.
At the time, Brian Walshe was at home awaiting sentencing in an unrelated art fraud case involving the sale of two fake Andy Warhol paintings and owed about $475,000 in restitution. Investigators testified that Ana Walshe had taken out a $2.7 million life insurance policy naming him as beneficiary.
With no body ever recovered, investigators have been unable to determine a cause of death — something the defense has tried to use to their advantage.
“There’s evidence that he lied to police, there’s evidence that he searched the internet, there’s evidence that he disposed of the body, but there is no proof in all of the evidence that you’ve heard and been presented that he ever once thought about harming the woman he loved,” defense attorney Larry Tipton told jurors during closing arguments.
Tipton urged jurors not to base their decision about whether Walshe killed his wife on the “upsetting and terrifying and at times, disgusting" acts he admitted to doing to her remains after she was dead. Instead, he said, they should focus on the evidence that he was not the one who caused her death.
Prosecutors, meanwhile, have pointed to Walshe’s actions as evidence of premeditation. In addition to other internet searches, Walshe specifically looked for “ways to dispose of body parts after murder."
Jurors were shown surveillance footage of him at stores like CVS, Walgreens and Lowe’s, where he purchased items including hydrogen peroxide and ammonia. They reviewed photos of tools that investigators testified tested positive for blood, including a hacksaw and a hatchet.
Prosecutors also connected him to items found at a trash processing facility near his mother’s home, including towels, a Tyvek suit, cleaning agents, a Prada purse, boots like those his wife was last seen wearing and her COVID-19 vaccination card.
Prosecutor Anne Yas argued during her closing statements that it was extremely unlikely that Ana Walshe, a 39-year-old in good health, would have dropped dead out of nowhere. She had a home gym at her Washington, D.C., home and regularly attended yoga and exercise classes, including on the morning of Dec. 31, 2022 — likely the last full day she was alive.
Yas said the only motivation Walshe could have for disposing of his wife’s body, as prosecutors allege, would be to hide evidence of what he did to her.
“The defendant didn’t want anyone to find Ana Walshe’s body and to know how she died, so the defendant cut up Ana’s body — the woman that he claimed to love — and he threw her in dumpsters,” she said.
Friends described Ana’s final weeks as emotionally strained. Gem Mutlu, who spent New Year’s Eve with the couple, said they appeared “very much in love,” though he later learned Ana and another man had exchanged messages that night.
Another friend, Alissa Kirby, told jurors Ana seemed exhausted by travel and stressed about her marriage. The two had recently grown close, walking together and going to karaoke; Kirby teared up when shown photos of them. She testified that Ana considered moving her family to Washington and said Brian often questioned whether she loved him.
Kirby also recounted two messages from Brian shortly before Ana was reported missing — one on Christmas, when he asked if she knew where Ana was, and another on Jan. 3: “I know we did this a week ago but have you heard from Ana?”
Family and fiends listen during listen during Brian Walshe's murder trial, Friday, Dec. 12, 2025, in Dedham, Mass. (Stuart Cahill/The Boston Herald via AP, Pool)
Defendant Brian Walshe, left, listens during his murder trial, Friday, Dec. 12, 2025, in Dedham, Mass. (Stuart Cahill/The Boston Herald via AP, Pool)
Defense attorney Larry Tipton gives his final statement during Brian Walshe's murder trial, Friday, Dec. 12, 2025, in Dedham, Mass. (Stuart Cahill/The Boston Herald via AP, Pool)
Prosecutor Anne Yas gives her final statement during Brian Walshe's murder trial, Friday, Dec. 12, 2025, in Dedham, Mass. (Stuart Cahill/The Boston Herald via AP, Pool)
Defendant Brian Walshe, left, chats with his lawyer Kelli Porges during his murder trial, Friday, Dec. 12, 2025, in Dedham, Mass. (Stuart Cahill/The Boston Herald via AP, Pool)
Diana Walshe listens to testimony as a photo of Brian Walshe's kitchen is projected on a monitor during his murder trial, Wednesday, Dec. 10, 2025, in Dedham, Mass. (Mark Stockwell/The Boston Herald via AP, Pool)
A snapshot of Alissa Kirby, right, a friend of murder victim Ana Walshe, at left, is shown on a monitor during Brian Walshe's murder trial, Wednesday, Dec. 10, 2025, in Dedham, Mass. (Mark Stockwell/The Boston Herald via AP, Pool)
Brian Walshe listens to testimony during his murder trial, Wednesday, Dec. 10, 2025, in Dedham, Mass. (Mark Stockwell /The Boston Herald via AP, Pool)
